Aprea Therapeutics Inc (NAS:APRE)
$ 5.8 -0.09 (-1.53%) Market Cap: 31.50 Mil Enterprise Value: 3.20 Mil PE Ratio: 0 PB Ratio: 1.30 GF Score: 42/100

Aprea Therapeutics Inc Annual Shareholders Meeting Transcript

Aug 23, 2023 / 01:00PM GMT
Release Date Price: $3.65 (-2.93%)
Operator

Welcome to the Annual Meeting for Aprea Therapeutics, Inc. Our host for today's call is Dr. Oren Gilad, President and CEO. (Operator Instructions)

I will now turn the call over to your host, Dr. Gilad. You may begin.

Oren Gilad;John Hamill
Aprea Therapeutics, Inc. - President and CEO;Aprea

Thank you, operator. Good morning. This meeting is officially called to order. I'm Oren Gilad, President and Chief Executive Officer of the company, and I will be presiding as Chairman of this meeting. I want to welcome you to the 2023 Annual Meeting of Stockholders of Aprea Therapeutics, Inc. John Hamill, Senior Vice President and Chief Financial Officer of the company, will act as Secretary of the meeting.

We have chosen to conduct this Annual Meeting in a virtual format. We're pleased to be able to hold a meeting that stockholders can attend virtually from anywhere, enabling everyone to engage with the company.

And with that, I will turn the meeting over to the Secretary for some brief introductory comments.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot